Pathology Grand Rounds - Challenges and new 2022 WHO in Grading of Prostate Cancer
During this activity, participants will review:
* The modified Gleason grading system included the current consensus in GUPS, ISUP and 2022 WHO
* The impact on the risk stratification and management of prostate cancer
* The limitations of modified Gleason system
* Integrating clinicopathologic parameters and other diagnostic tools (MRI imaging, genomic tests, AI) for personalized treatment decision making
Type: LECTURE/TALK